Tripos reviews its options | Chemical & Engineering News
Volume 84 Issue 3 | p. 16 | Concentrates
Issue Date: January 16, 2006

Tripos reviews its options

Department: Business

Tripos has retained the advisory firm Seven Hills Partners to help it explore various strategic options, including mergers and acquisitions, becoming a private company, and separating its businesses in drug discovery informatics and chemistry research. Tripos' announcement comes three weeks after the company disclosed that it will cut staff in its chemistry research business now that a four-year program to make druglike molecules for Pfizer has ended. Separately, Tripos says that Wyeth will pay $5 million to license Tripos' informatics technology for use in drug discovery.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment